A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Academic Article uri icon

Overview

MeSH Major

  • Anticoagulants
  • Idiopathic Pulmonary Fibrosis
  • Warfarin

abstract

  • This study did not show a benefit for warfarin in the treatment of patients with progressive IPF. Treatment with warfarin was associated with an increased risk of mortality in an IPF population who lacked other indications for anticoagulation.

publication date

  • July 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3400994

Digital Object Identifier (DOI)

  • 10.1164/rccm.201202-0314OC

PubMed ID

  • 22561965

Additional Document Info

start page

  • 88

end page

  • 95

volume

  • 186

number

  • 1